These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 948026)

  • 21. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum ascorbic acid concentrations in previously unsupplemented greyhounds after administration of a single dose of ascorbic acid intravenously or per os.
    Scott KC; Hill RC; Lewis DD; Gronwall R; Sundstrom DA; Jones GL; Harper J
    J Anim Physiol Anim Nutr (Berl); 2002 Aug; 86(7-8):222-8. PubMed ID: 15379908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An effect of sulfur nutrition on the metabolism of salicylamide.
    Kurzynske JS; Smith JT
    Drug Nutr Interact; 1982; 1(2):169-75. PubMed ID: 6926825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chronic co-administration of metformin and vitamin C on plasma glucose and lipid concentrations in normal rats.
    Adeneye AA; Amole OO; Agbaje EO; Izegbu MC; Elias SO
    Afr J Med Med Sci; 2007 Jun; 36(2):149-54. PubMed ID: 19205578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 5-fluorouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats.
    Yoshisue K; Nagayama S; Shindo T; Kawaguchi Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1166-75. PubMed ID: 11356943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfoconjugation and glucuronidation of salicylamide in isolated rat hepatocytes.
    Koike M; Sugeno K; Hirata M
    J Pharm Sci; 1981 Mar; 70(3):308-11. PubMed ID: 7264898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related differences in salicylamide and acetaminophen conjugation in man.
    Alam SN; Roberts RJ; Fischer LJ
    J Pediatr; 1977 Jan; 90(1):130-5. PubMed ID: 830879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of salicylamide and five metabolites in biological fluids by high-performance liquid chromatography.
    Morris ME; Levy G
    J Pharm Sci; 1983 Jun; 72(6):612-7. PubMed ID: 6875820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced prehepatic extraction of nicardipine in the presence of pioglitazone in rats.
    Choi JS; Koh YY; Chung JH; Choi DH; Han HK
    J Pharm Pharmacol; 2008 Oct; 60(10):1403-7. PubMed ID: 18812034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of carbonated beverages and of an antiemetic containing carbohydrate and phosphoric acid on riboflavin bioavailability and salicylamide biotransformation in humans.
    Houston JB; Levy G
    J Pharm Sci; 1975 Sep; 64(9):1504-7. PubMed ID: 1185567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-dependent, plasma-sulfate-independent kinetics of salicylamide in dogs.
    Waschek JA; Fielding RM; Tozer TN; Effeney DJ; Pond SM
    J Pharmacokinet Biopharm; 1988 Apr; 16(2):151-9. PubMed ID: 3418492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
    Pang KS; Barker F; Schwab AJ; Goresky CA
    J Pharmacol Exp Ther; 1994 Jul; 270(1):285-95. PubMed ID: 8035326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic fate of partially depolymerized shark chondroitin sulfate in man.
    Ronca G; Conte A
    Int J Clin Pharmacol Res; 1993; 13 Suppl():27-34. PubMed ID: 7995679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
    Pond SM; Waschek JA; Mahacha V; Fielding RM; Effeney DJ; Tozer TN
    J Pharmacol Exp Ther; 1988 Apr; 245(1):291-3. PubMed ID: 3361447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the absorption of ascorbic acid in man.
    Kallner A; Hartmann D; Hornig D
    Int J Vitam Nutr Res; 1977; 47(4):383-8. PubMed ID: 591210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of drug biotransformation by vitamin C in man.
    Houston JB; Levy G
    Nature; 1975 May; 255(5503):78-9. PubMed ID: 1128674
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of sulfate formation in biotransformation of salicylamide in man.
    Levy G; Matsuzawa T
    J Pharm Sci; 1966 Feb; 55(2):222-3. PubMed ID: 5923280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.